Organizer
Phenomenex
Phenomenex
Phenomenex is a global technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers in industrial, government and academic laboratories. From drug discovery and pharmaceutical development to disease diagnosis, food safety to environmental analysis, Phenomenex chromatography solutions accelerate science and help researchers improve global health and well-being.
Tags
Consumables
Columns
HPLC
LinkedIn Logo

Method Development Strategies for Peptide Analysis

RECORD | Already taken place Th, 20.10.2022
Topics: The basics of peptides, A deep dive into different phase chemistries, Understand critical parameters.
Go to the webinar
Phenomenex: Method Development Strategies for Peptide Analysis
Phenomenex: Method Development Strategies for Peptide Analysis

Key Learning Points:

  • Learn about the basics of peptides and the digestion of proteins to peptides
  • A deep dive into different phase chemistries used and the method development design space for optimizing the chromatography
  • Understand critical parameters and the importance of pressure testing your methods to ensure robustness

Presenter: Helen Whitby, PhD (Senior Product Manager, Bioseparations Phenomenex)

Dr. Helen Whitby is the senior product manager for biopharma at Phenomenex. Helen has been with Phenomenex since 2007, starting in the UK sales team as a bulk and prep specialist before joining the technical team in 2016. Helen spent 6 years as a biopharma specialist in the technical team supporting all our biopharma products globally before moving to product management in 2022.

Helen has a PhD from the University of Manchester working on analogues of Shikimic acid to treat malaria. Prior to joining Phenomenex, Helen spent a year as a Post-doctoral researcher at the University of Illinois in Chicago, where she studied electron-deficient divalent reactive intermediates, specifically nitrenium ions for the development of antiviral agents to treat Ebola.

Phenomenex
LinkedIn Logo
 

Related content

Comprehensive and Robust Analysis of Ultrashort- to Long-Chain PFAS, PAE, OPE, and PAH

Applications
| 2026 | Agilent Technologies
Instrumentation
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Manufacturer
Agilent Technologies, Plasmion
Industries
Environmental

UPLC™ Separation of Fifteen Bisphenols Using a Waters Acquity™ Biphenyl RP Column with MaxPeak™ Premier Technology and UV Detection

Applications
| 2026 | Waters
Instrumentation
Consumables, LC columns, HPLC
Manufacturer
Waters
Industries
Pharma & Biopharma

Achieving Low‑ppb Bisphenol Quantitation with the Agilent InfinityLab Pro iQ Mass Detector

Applications
| 2026 | Agilent Technologies
Instrumentation
LC/MS, LC/SQ
Manufacturer
Agilent Technologies
Industries
Materials Testing

ECL detection of fentanyl

Applications
| 2026 | Metrohm
Instrumentation
Electrochemistry
Manufacturer
Metrohm
Industries
Forensics

Early-stage drug metabolite quantitation without radiolabels

Applications
| 2026 | Thermo Fisher Scientific
Instrumentation
HPLC, LC/MS, LC/SQ
Manufacturer
Thermo Fisher Scientific
Industries
Pharma & Biopharma, Metabolomics
Other projects
GCMS
ICPMS
Follow us
FacebookX (Twitter)LinkedInYouTube
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike